Alzamend Neuro Inc (ALZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 07-2024 | 04-2024 | 01-2024 | 10-2023 | 07-2023 | |
| Operating Expenses | 962 | 850 | 2,660 | 2,902 | 3,526 |
| Operating Income | -962 | -850 | -2,660 | -2,902 | -3,526 |
| Interest Expense | 12 | 2 | 3 | 4 | 2 |
| Pre-tax Income | -974 | -852 | -2,662 | -2,906 | -3,528 |
| Net Income Continuous | -974 | -852 | -2,662 | -2,906 | -3,528 |
| Net Income | $-974 | $-852 | $-2,662 | $-2,906 | $-3,528 |
| EPS Basic Total Ops | -11.42 | -10.10 | -33.93 | -39.87 | -48.42 |
| EPS Basic Continuous Ops | -11.42 | -11.91 | -33.97 | -39.85 | -48.38 |
| EPS Diluted Total Ops | -11.42 | -10.10 | -33.93 | -39.87 | -48.42 |
| EPS Diluted Continuous Ops | -11.42 | -11.91 | -33.97 | -39.85 | -48.38 |
| EPS Diluted Before Non-Recurring Items | -11.25 | N/A | -34.20 | N/A | N/A |
| EBITDA(a) | $-950 | $-837 | $-2,647 | $-2,889 | $-3,513 |